Conclusion: These findings link the G894T NOS3 polymorphism to heightened STEMI risk, particularly in patients with diabetes, and highlight the association of DDAH2 SNPs with CAD, emphasizing the prevalence of GG genotypes in STEMI cases. This evidence concerns the gene NOS3 and diabetes mellitus.